Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1321 | 991 | 1384 | 1869 | 3304 | 5546 |
Fund Return | 32.15% | -0.91% | 38.45% | 23.17% | 27% | 18.69% |
Place in category | 37 | 34 | 57 | 71 | 63 | 24 |
% in Category | 17 | 15 | 25 | 46 | 45 | 18 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Kotak Equity Arbitrage M Div Dir | 549.41B | 7.73 | 7.02 | 6.53 | ||
Kotak Equity Arbitrage M Div | 549.41B | 7.15 | 6.40 | 5.82 | ||
Kotak Equity Arbitrage Fund Growth | 549.41B | 7.15 | 6.40 | 6.04 | ||
Kotak Equity Arbitrage Growth Dir | 549.41B | 7.73 | 7.02 | 6.61 | ||
Kotak Emerging Equity Scheme Growth | 506.27B | 32.15 | 23.17 | 18.87 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
HDFC MidCap Opportunities Div | 760.61B | 26.48 | 28.00 | 17.98 | ||
HDFC MidCap Opportunities Growth | 760.61B | 26.49 | 28.04 | 18.25 | ||
HDFC MidCap Opportunities Dir Div | 760.61B | 27.25 | 28.88 | 18.99 | ||
HDFC MidCap Opportunities Dir Gr | 760.61B | 27.26 | 28.92 | 19.22 | ||
Kotak Emerging Equity Scheme Growth | 506.27B | 32.15 | 23.17 | 18.87 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Persistent Systems | INE262H01021 | 4.16 | 6,543.55 | -0.09% | |
Oracle | INE881D01027 | 3.51 | 12,475.00 | +0.36% | |
Mphasis | INE356A01018 | 3.31 | 3,169.25 | -0.38% | |
Oberoi Realty | INE093I01010 | 3.11 | 2,305.65 | -0.43% | |
Fortis Healthcare | INE061F01013 | 3.05 | 677.40 | -1.39% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review